Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Profound Medical (PROF) Gains from Sales and Divestitures (2023 - 2025)

Profound Medical has reported Gains from Sales and Divestitures over the past 3 years, most recently at $171618.0 for Q4 2025.

  • Quarterly results put Gains from Sales and Divestitures at $171618.0 for Q4 2025, down 24.98% from a year ago — trailing twelve months through Dec 2025 was $171618.0 (down 24.98% YoY), and the annual figure for FY2025 was $171618.0, down 24.98%.
  • Gains from Sales and Divestitures for Q4 2025 was $171618.0 at Profound Medical, up from $145448.0 in the prior quarter.
  • Over the last five years, Gains from Sales and Divestitures for PROF hit a ceiling of $228774.0 in Q4 2024 and a floor of $10000.0 in Q4 2023.
  • Median Gains from Sales and Divestitures over the past 3 years was $79390.5 (2025), compared with a mean of $97084.3.
  • Biggest five-year swings in Gains from Sales and Divestitures: soared 2187.74% in 2024 and later fell 24.98% in 2025.
  • Profound Medical's Gains from Sales and Divestitures stood at $10000.0 in 2023, then soared by 2187.74% to $228774.0 in 2024, then fell by 24.98% to $171618.0 in 2025.
  • The last three reported values for Gains from Sales and Divestitures were $171618.0 (Q4 2025), $145448.0 (Q3 2025), and $13333.0 (Q2 2025) per Business Quant data.